13F-HR filed by SECTOR GAMMA AS
SECTOR GAMMA AS filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 26 holding rows worth $531,532,000.
- Accession
- 0001475373-17-000001
- Filer
- CIK 1475373
- Filed
- 2017-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2016
A holdings report, 26 entries on the cover page, a total value of $531,532,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $531,532,000 with VALUE read as thousands by filing date, 13F file number 028-13612. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerCrestline Management, LP028-14917
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 667,050 | $49,062,000 | thousands by filing date | |
| BAXTER INTL INC | 071813109 | COM | 952,833 | $42,249,000 | thousands by filing date | |
| Abbott Laboratories | 002824100 | COM | 976,590 | $37,511,000 | thousands by filing date | |
| REVVITY INC | 714046109 | COM | 623,408 | $32,511,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 1,972,678 | $30,162,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 1,255,580 | $27,158,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 449,290 | $26,257,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 359,290 | $25,729,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 146,961 | $25,039,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 333,950 | $24,602,000 | thousands by filing date | |
| INTEGRA LIFESCIENCES HLDGS C | 457985208 | COM NEW | 281,207 | $24,125,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 313,004 | $21,096,000 | thousands by filing date | |
| BIO RAD LABS INC | 090572207 | CL A | 114,042 | $20,788,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 140,810 | $20,244,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 283,410 | $16,684,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 115,200 | $16,180,000 | thousands by filing date | |
| PATTERSON COS INC | 703395103 | COM | 386,232 | $15,847,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 855,265 | $12,872,000 | thousands by filing date | |
| CIGNA CORPORATION | 125509109 | COM | 95,270 | $12,708,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 67,974 | $9,750,000 | thousands by filing date | |
| LIFEPOINT HEALTH INC | 53219L109 | COM | 164,714 | $9,356,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 520,091 | $7,755,000 | thousands by filing date | |
| ACCENDRA HEALTH INC | 690732102 | COM | 214,172 | $7,558,000 | thousands by filing date | |
| IMPAX LABORATORIES INC | 45256B101 | COM | 499,153 | $6,614,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 48,500 | $5,934,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 252,080 | $3,741,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001475373-17-000001 | this filing | 2017-02-14 | acceptance time not in the bulk data set |